Today: 22 March 2026
Browse Category

Stock Market 13 January 2026

BHP stock rises as it stays out of the Rio-Glencore chase — what investors watch next

BHP stock rises as it stays out of the Rio-Glencore chase — what investors watch next

BHP’s U.S. shares rose 1.7% to $62.80 after sources said the miner won’t pursue a rival bid for Glencore, instead watching Rio Tinto’s takeover talks. BHP declined to comment. Rio Tinto’s U.S. shares gained 2.1% to $82.88, while Freeport-McMoRan jumped 3.8%. BHP granted nearly 4 million performance rights in a routine filing, listing 5.08 billion shares outstanding.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 13.01.2026

WHSP Holdings insiders, led by Robert Millner, bought AU$3.4 million in shares over 12 months with no insider sales; insiders now hold 5.4% of the company. JPMorgan Chase dropped over 3% midday after missing estimates, while Moderna surged 14% on a strong 2025 sales forecast. Arch Capital Group trades near $90.77 as momentum slows, with analysts’ targets averaging $108.31. BofA Securities upgraded Coinbase Global to Buy, setting a $340 target.
Adobe stock slides as Goldman turns bearish; CPI and Firefly AI push set up Tuesday

Adobe stock slides as Goldman turns bearish; CPI and Firefly AI push set up Tuesday

Adobe fell 1.9% to $327.65 Monday, underperforming the S&P 500 and Dow, after Goldman Sachs initiated coverage with a Sell rating and $290 target. The stock is about 30% below its 52-week high amid analyst skepticism over AI monetization and competitive pressure. Trading volume was slightly below average. Investors await December CPI data Tuesday morning.
Merck stock in focus as MRK lifts $70 billion mid-2030s target and points past Keytruda

Merck stock in focus as MRK lifts $70 billion mid-2030s target and points past Keytruda

Merck raised its long-term revenue forecast for new products to $70 billion by the mid-2030s, lifting its cardiometabolic and respiratory outlook to $20 billion and infectious disease to $15 billion. Shares fell 1.2% to $109.19. Johnson & Johnson rose 2.6%, Eli Lilly gained 1.6%, and Pfizer slipped 0.8%. Merck said its pipeline could offset Keytruda’s loss of exclusivity by 2026.
Oklo stock slips as insiders sell shares and traders reassess Meta nuclear deal

Oklo stock slips as insiders sell shares and traders reassess Meta nuclear deal

Oklo Inc shares fell 2.7% to $102.50 Monday, reversing some of last week’s surge after Meta Platforms announced a 20-year nuclear power deal involving Oklo. A regulatory filing showed Oklo COO Caroline Cochran sold 328,372 shares for about $32.5 million last week. Oklo said Meta’s agreement supports a planned 1.2-gigawatt power campus in Ohio, with first power targeted for 2030.
13 January 2026
Texas Instruments stock dips into CPI week as TXN heads toward earnings

Texas Instruments stock dips into CPI week as TXN heads toward earnings

Texas Instruments shares fell 0.7% to $189.07 on Monday, lagging behind record highs in the S&P 500 and Dow. Investors are watching Tuesday’s U.S. inflation data and Texas Instruments’ Jan. 27 earnings for signals on industrial demand. Semiconductor stocks showed mixed moves, with Qualcomm and Analog Devices posting steeper declines. The average analyst target for Texas Instruments stands at $190.40.
KLA stock notches new 52-week high as chip-tool shares firm; Susquehanna lifts target

KLA stock notches new 52-week high as chip-tool shares firm; Susquehanna lifts target

KLA shares rose 2.0% to a record $1,428.17 Monday after Susquehanna raised its price target to $1,500, maintaining a Neutral rating. Trading volume was 854,084 shares, below average. Applied Materials gained 2.0% and Lam Research added nearly 1.0%, lifting the iShares Semiconductor ETF by about 0.5%. KLA reports fiscal Q2 results Jan. 29 after market close.
EchoStar stock jumps to record close — what traders watch before Tuesday

EchoStar stock jumps to record close — what traders watch before Tuesday

EchoStar shares surged 6.7% to $128.03 Monday, then slipped 1.5% after hours as traders tracked spectrum sales and looming FCC auction deadlines. The company’s $2.6 billion spectrum deal with SpaceX and scrutiny from lawmakers have driven volatility. TD Cowen raised its price target to $158. Investors face key FCC filing dates in February and April. Holders of EchoStar’s 2030 convertible notes have a new conversion window through March.
13 January 2026
Vistra stock rises after debt offering as Meta nuclear deal drives fresh price targets

Vistra stock rises after debt offering as Meta nuclear deal drives fresh price targets

Vistra shares rose 3.7% to $172.58 Monday after the company launched a senior secured notes offering to help fund its $4 billion acquisition of Cogentrix. The move follows a 20-year nuclear power supply deal with Meta, covering 2,609 megawatts. UBS raised its price target on Vistra to $233, citing expected cash flow growth from the Meta contracts and nuclear plant upgrades. Vistra expects to close the Cogentrix deal in mid-to-late 2026.
13 January 2026
Wells Fargo stock slides as Trump’s credit-card cap talk hits banks ahead of earnings

Wells Fargo stock slides as Trump’s credit-card cap talk hits banks ahead of earnings

Wells Fargo shares fell about 1% to $94.96 on Monday after President Donald Trump proposed a one-year 10% cap on credit-card interest rates. The decline came ahead of the bank’s fourth-quarter earnings, due Wednesday morning. Analysts warned a rate cap could restrict credit access and hurt card profits. Broader financial stocks also retreated as traders watched for signs of policy risk and consumer strength.
AST SpaceMobile stock in focus after AT&T FirstNet sets first-half 2026 satellite target

AST SpaceMobile stock in focus after AT&T FirstNet sets first-half 2026 satellite target

AST SpaceMobile shares closed up 0.7% at $98.39 after AT&T’s FirstNet announced plans to launch satellite connectivity for first responders by mid-2026. AST recently launched its BlueBird 6 satellite and aims for up to 60 satellites by the end of 2026. Investors remain focused on the company’s ability to accelerate launches and expand ground gateways. The stock is up about 35% year-to-date.
Pfizer stock dips as CEO says obesity-drug cash-pay demand looks “almost like Viagra”

Pfizer stock dips as CEO says obesity-drug cash-pay demand looks “almost like Viagra”

Pfizer shares fell 0.8% to $25.27 after CEO Albert Bourla compared the obesity drug cash-pay market to Viagra’s early days. The company, which acquired Metsera for up to $10 billion, aims to start up to 10 Phase 3 trials for Metsera’s GLP-1 drug by end-2026. Eli Lilly and Novo Nordisk shares rose, while Pfizer trails rivals in the obesity market.
SoFi stock drops late Monday as Trump’s credit-card cap idea collides with loan-market nerves

SoFi stock drops late Monday as Trump’s credit-card cap idea collides with loan-market nerves

SoFi shares fell 3% to $26.60 Monday after a volatile session, following President Trump’s proposal for a 10% cap on credit-card APRs. CEO Anthony Noto backed the cap, but analysts and investors warned it could restrict credit and shift borrowers to other debt. Consumer-credit stocks broadly declined. Markets await U.S. inflation data Tuesday and SoFi’s earnings on January 30.
13 January 2026
GE Aerospace stock heads into earnings week as Airbus flags engine delays and brokers tweak targets

GE Aerospace stock heads into earnings week as Airbus flags engine delays and brokers tweak targets

GE Aerospace shares closed up 0.8% at $324.17 after Wolfe Research raised its price target, while Citi lowered its own but kept a Buy rating. Airbus warned that Pratt & Whitney engine deliveries remain “very, very late,” with delays now stretching into 2026. GE reports earnings Jan. 22. RTX shares rose 2.8%.
Alnylam stock sinks nearly 7% after Amvuttra revenue miss; what to watch next for ALNY

Alnylam stock sinks nearly 7% after Amvuttra revenue miss; what to watch next for ALNY

Alnylam shares fell 6.7% to $370.91 after preliminary fourth-quarter sales for Amvuttra missed Wall Street estimates. The company reported about $827 million in Amvuttra revenue, below analyst expectations of $852 million. Alnylam set 2026 product revenue guidance at $4.9 billion to $5.3 billion and outlined a new five-year plan. Full results are due in February.

Stock Market Today

  • Independent Bank (INDB) May Be Undervalued Despite Recent Price Gains
    March 21, 2026, 7:50 PM EDT. Independent Bank's (INDB) share price is up 22.6% over the past year but has dipped 9.2% in the last 30 days. The stock trades around $74.70, with valuation analysis indicating it may still be undervalued by approximately 15.7%. The Excess Returns model, which assesses profit above shareholders' required returns, values the stock at about $88.62 per share compared to its current price. Independent Bank's return on equity stands at 7.36%, slightly above its cost of equity, suggesting moderate excess returns. Despite investor interest and recent market fluctuations, the bank scores low on some standard valuation checks, warranting cautious examination. These insights come amid broader shifts in sentiment toward U.S. regional banks and financial stocks.
Go toTop